Svan, I agree with your post and will admit GC has
Post# of 30028
Posted On: 08/26/2015 7:59:16 PM
Svan, I agree with your post and will admit GC has turned a fledgling biotech into a company with potential.
However how can a CEO who has over promised and under delivered countless times be upset when the shareholders have finally had enough?
1) Codes for Lympro?
2) Mentioning Partners and only get a service agreement?
3) The AAIC debacle from last July?
4) Money Runners?
5) Relationship with a dirty government official?
6) RUO market of 150 mil for Lympro, 0 to date?
7) 50 K for a silver sponsorship and a rehash of old data?
Uplist from strength possible RS not needed?
9) Authorization of 35 mil shares without guidance?
10) Institutional Investors?
These are just a quick list of why so many are abandoning ship, add that with GC's twitter tantrum blaming shareholders as the icing on the cake and you see the catastrophe we call a PPS.
Time will tell if they pull the rabbit out of the hat but from their track record most have their doubts.
However how can a CEO who has over promised and under delivered countless times be upset when the shareholders have finally had enough?
1) Codes for Lympro?
2) Mentioning Partners and only get a service agreement?
3) The AAIC debacle from last July?
4) Money Runners?
5) Relationship with a dirty government official?
6) RUO market of 150 mil for Lympro, 0 to date?
7) 50 K for a silver sponsorship and a rehash of old data?
Uplist from strength possible RS not needed? 9) Authorization of 35 mil shares without guidance?
10) Institutional Investors?
These are just a quick list of why so many are abandoning ship, add that with GC's twitter tantrum blaming shareholders as the icing on the cake and you see the catastrophe we call a PPS.
Time will tell if they pull the rabbit out of the hat but from their track record most have their doubts.
(0)
(0)Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼